Colorectal cancer patients with African ancestry have fewer clinically actionable alterations than white patients: Study

Genomic profiling of patients who were treated for colorectal cancer at a major U.S. cancer center showed that patients with African ancestry had fewer actionable mutations than patients with European ancestry and were less likely to qualify for treatment with immunotherapy, according to data presented at the AACR Annual Meeting 2023, held April 14-19.